To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

MJH Begemann; IA Thompson; W Veling; SS Gangadin; CNW Geraets; E van 't Hag; JM Beveren; L de Haan; IEC Sommer

doi:10.1186/s13063-019-3822-5

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

MJH Begemann, IA Thompson, W Veling, SS Gangadin, CNW Geraets, E van 't Hag, JM Beveren, L de Haan, IEC Sommer

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

3 Downloads (Pure)

Original language	English
Article number	147
Journal	Trials
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13063-019-3822-5
Publication status	Published - 2020

Access to Document

10.1186/s13063-019-3822-5

Repub-124654-OA.pdfFinal published version, 1.14 MB

Cite this

Begemann, MJH., Thompson, IA., Veling, W., Gangadin, SS., Geraets, CNW., van 't Hag, E., Beveren, JM., de Haan, L., & Sommer, IEC. (2020). To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. Trials, 21(1), [147]. https://doi.org/10.1186/s13063-019-3822-5

Begemann, MJH ; Thompson, IA ; Veling, W ; Gangadin, SS ; Geraets, CNW ; van 't Hag, E ; Beveren, JM ; de Haan, L ; Sommer, IEC. / To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. In: Trials. 2020 ; Vol. 21, No. 1.

@article{bad887c87b4146a78b4bf75bd0643f1e,

title = "To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial",

author = "MJH Begemann and IA Thompson and W Veling and SS Gangadin and CNW Geraets and {van 't Hag}, E and JM Beveren and {de Haan}, L and IEC Sommer",

year = "2020",

doi = "10.1186/s13063-019-3822-5",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

number = "1",

}

Begemann, MJH, Thompson, IA, Veling, W, Gangadin, SS, Geraets, CNW, van 't Hag, E, Beveren, JM, de Haan, L & Sommer, IEC 2020, 'To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial', Trials, vol. 21, no. 1, 147. https://doi.org/10.1186/s13063-019-3822-5

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial. / Begemann, MJH; Thompson, IA; Veling, W; Gangadin, SS; Geraets, CNW; van 't Hag, E; Beveren, JM; de Haan, L; Sommer, IEC.

In: Trials, Vol. 21, No. 1, 147, 2020.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial

AU - Begemann, MJH

AU - Thompson, IA

AU - Veling, W

AU - Gangadin, SS

AU - Geraets, CNW

AU - van 't Hag, E

AU - Beveren, JM

AU - de Haan, L

AU - Sommer, IEC

PY - 2020

Y1 - 2020

U2 - 10.1186/s13063-019-3822-5

DO - 10.1186/s13063-019-3822-5

M3 - Article

VL - 21

JO - Trials

JF - Trials

SN - 1745-6215

IS - 1

M1 - 147

ER -